2014
DOI: 10.1093/ehjci/jet256
|View full text |Cite
|
Sign up to set email alerts
|

Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis

Abstract: Brachial FMD and PAT are independent predictors of CV events and all-cause mortality. Further research to evaluate the prognostic utility of PAT is necessary to compare it with FMD as a non-invasive endothelial function test in clinical practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
175
0
4

Year Published

2016
2016
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 227 publications
(186 citation statements)
references
References 50 publications
7
175
0
4
Order By: Relevance
“…In addition, reductions of 1 mmol in LDL-cholesterol have been associated with a 23% reduction in myocardial infarction or coronary death and 12% reduction in all-cause mortality [39]. In relation with our findings on FMD, several recent systematic reviews and metaanalysis indicate that increases in FMD of 1% increase, independently of confounding factors, are associated with reductions ranging from 10-13% in the risk of cardiovascular events [40][41][42].…”
Section: Implications For Health and Future Researchsupporting
confidence: 77%
“…In addition, reductions of 1 mmol in LDL-cholesterol have been associated with a 23% reduction in myocardial infarction or coronary death and 12% reduction in all-cause mortality [39]. In relation with our findings on FMD, several recent systematic reviews and metaanalysis indicate that increases in FMD of 1% increase, independently of confounding factors, are associated with reductions ranging from 10-13% in the risk of cardiovascular events [40][41][42].…”
Section: Implications For Health and Future Researchsupporting
confidence: 77%
“…Parameters measured by arterial tonometry have been found to be associated with the left ventricular hypertrophy, 35 CVD risk factors, 36 CVD events, 37,38 and all-cause mortality. 37,38 Accuracy of arterial tonometry is comparable to traditional invasive vascular testing methods. 39 However, further research is needed before it can be widely used in a clinical setting.…”
Section: Noninvasive Vascular Testing Measuresmentioning
confidence: 99%
“…One approach is to evaluate the endothelial NO-availability by assessing the flow-induced and NO-dependent vasodilation (using the FMD test, for instance). It appears that the impairment of such a response, dubbed "endothelial dysfunction", correlates with the presence and the progression of various forms of CVD, and that the measures preventing CVD also reduce the endothelial dysfunction [24,27], supporting the view that disrupted endothelial homeostasis underlies the mechanism of CVD.…”
Section: Nitric Oxide and Ros Interactions Vs The Pro-atherosclerotimentioning
confidence: 98%